Talking Business #1 Interview with Spyros Papapetropoulos from Bionomics

Spiros Papetropoulos, CEO of Bionomics 3:51 Says up until now social anxiety is treated with drugs like Valium which don’t work for everyone and run the risk of addiction. 10:56 Says Bionomics is now preparing work for health authorities in the US for its BNC210 programs to treat social anxiety   SpyrosPapapetropoulosFeb7 .mp3 AMP Capital chief economist Shane Oliver  13:06 Says that while it’s not certain, AMP forecasts the Reserve Bank of Australia will ease interest rates in February and then adopt a cautious approach to rates21:06 Predicts investors will have a a tougher more volatile market in 2025 compared with the last two years, with returns of about 7-8%. Follow my socials on:https://twitter.com/leongettlerhttps://www.instagram.com/leongettler/https://www.linkedin.com/in/leongettler/https://www.facebook.com/talkingbusinesspodcasthttps://business.google.com/dashboard/l/17460167277811417147?hl=en&gmbsrc=au-en-z-z-z-gmb-s-119-u~mhp-ns_hom_8-u&omec=EI_z6RYYASIBATIBATotZ21ic3JjPWF1LWVuLXotei16LWdtYi1zLTExOS11fm1ocC1uc19ob21fOC11QAFKEwjq4cCIj5D3AhXNnWMKHUB5Cqg%3Dhttps://www.youtube.com/c/LeonGettler/discussion?app=desktop  Hosted on Acast. See acast.com/privacy for more information.